TAIM
IONS icon

TD Ameritrade Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

TD Ameritrade Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,000
Closed -$283K – 657
2021
Q1 		$283K Hold
5,000
– – ﹤0.01% 196
2020
Q4 		$283K Buy
+5,000
New +$249K ﹤0.01% 196

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

TD Ameritrade Investment Management's IONS Position: Q2 2021 in Review

TD Ameritrade Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 5,000 shares — an estimated $283K sold.

TD Ameritrade Investment Management first reported a position in IONS in Q4 2020 and held it in 2 quarters. The position peaked at $283K in Q1 2021. 337 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

  • TD Ameritrade Investment Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 5,000 Ionis Pharmaceuticals shares in Q2 2021, an estimated $283K.
  • TD Ameritrade Investment Management first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 2 quarters.
  • TD Ameritrade Investment Management's Ionis Pharmaceuticals position peaked at $283K in Q1 2021.
  • 337 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on TD Ameritrade Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.